MYLAN PHARMACEUTICALS INC.
MORGANTOWN, WEST VIRGINIA
PERM (Green Card) Statistics
Total PERM Cases
17
Certified Cases
6
Success Rate
35%
Average Wage
β
H-1B Visa Statistics
Total H-1B Cases
44
Certified Cases
39
Success Rate
89%
Average Wage
$91966
MYLAN PHARMACEUTICALS INC. Top PERM Job Titles
Product Steward
1
MYLAN PHARMACEUTICALS INC. PERM Case Status
Certified-Expired
10
59%
Certified
6
35%
Withdrawn
1
6%
MYLAN PHARMACEUTICALS INC. Top H-1B Job Titles
PRODUCT STEWARD
5
Scientist
4
SENIOR SCIENTIST
2
SCIENTIST
2
Director Product Health and Performance
2
SENIOR REGULATORY AFFAIRS SPECIALIST
2
PHARMACEUTICAL TECHNICAL INVESTIGATOR/Wβ¦
2
FORMULATION SCIENTIST
2
QUALITY ENGINEER
2
SENIOR FORMULATION SCIENTIST
2
MYLAN PHARMACEUTICALS INC. H-1B Case Status
CERTIFIED
24
55%
Certified
15
34%
CERTIFIED-WITHDRAWN
4
9%
WITHDRAWN
1
2%
MYLAN PHARMACEUTICALS INC. H-1B Wage Range
$48277
Minimum
$91966
Average
$163037
Maximum
MYLAN PHARMACEUTICALS INC. PERM Cases (17 total)
| Case Number | Status | Job Title | Wage | Decision Date |
|---|---|---|---|---|
| A-19337-90171 | Certified |
Product Steward
|
β | May 13, 2020 |
| A-17304-05164 | Certified |
β
|
β | April 17, 2018 |
| A-17291-00176 | Certified-Expired |
β
|
β | March 19, 2018 |
| A-16350-81180 | Certified |
β
|
β | April 11, 2017 |
| A-16349-80862 | Certified-Expired |
β
|
β | March 2, 2017 |
| A-16203-34681 | Certified-Expired |
β
|
β | Nov. 14, 2016 |
| A-15322-41132 | Certified |
β
|
β | May 10, 2016 |
| A-15148-80620 | Certified-Expired |
β
|
β | Dec. 9, 2015 |
| A-14015-33080 | Certified |
β
|
β | July 9, 2015 |
| A-14108-61705 | Certified-Expired |
β
|
β | Jan. 30, 2015 |
| A-14154-74572 | Certified-Expired |
β
|
β | Nov. 28, 2014 |
| A-13079-49778 | Withdrawn |
β
|
β | July 15, 2013 |
| A-12173-74558 | Certified-Expired |
β
|
β | Aug. 30, 2012 |
| A-12171-73412 | Certified-Expired |
β
|
β | Aug. 30, 2012 |
| A-12160-70094 | Certified-Expired |
β
|
β | Aug. 29, 2012 |
| A-11195-92718 | Certified |
β
|
β | Sept. 29, 2011 |
| A-10357-41592 | Certified-Expired |
β
|
β | Jan. 26, 2011 |